Format

Send to

Choose Destination
Leukemia. 2019 Apr 9. doi: 10.1038/s41375-019-0452-6. [Epub ahead of print]

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Author information

1
Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France.
2
Department of Laboratory Medicine, Division of Hematology and Transfusion medicine, Lund University, Lund, Sweden.
3
Biological Statistics and Computational Biology, Cornell University, Ithaca, NY, USA.
4
Medicine, Weill Cornell Medical College, New York, NY, USA.
5
ProfilExpert, Lyon, France.
6
Hospices Civils de Lyon, Lyon, France.
7
Medical Oncology Service, Hospitales Universitarios Regional y Virgen de la Victoria; Institute of Biomedical Research in Malaga (IBIMA), CIMES, University of Málaga, Málaga, Spain.
8
INSERM 1052, CNRS 5286, CRCL, Lyon, France.
9
University of Lyon, Lyon, France.
10
INSERM, UMR_S 938, Paris, France.
11
AP-HP, Hôpital Saint Antoine, Departement d'hematologie et de therapie cellulaire, Paris, France.
12
Sorbonne Universites, UPMC Univ Paris 06, UMR_S 938, Paris, France.
13
IUC-Oncopole and CRCT INSERM U1037, Toulouse, France.
14
Inserm CIC 1402 & Service d'Hématologie et Thérapie Cellulaire, CHU La Miletrie, Poitiers, France.
15
Hôpital Claude Huriez, CHRU, Lille, France.
16
Service de Medecine Interne, CHU Rennes, Rennes, France.
17
Faculte de Medecine, Universite de Rennes 1, Rennes, France.
18
INSERM UMR U1236, Rennes, France.
19
Unite d'Hematologie et d'Oncologie, Centre Hospitalier, Perigueux, France.
20
Hematologie Clinique, CHU de Reims, Reims, France.
21
Service d'Onco hematologie, CH Avignon, Avignon, France.
22
Hematologie et pathologies de la coagulation, Grand Hôpital de Charleroi, Charleroi, Belgium.
23
Centre Jean Bernard, Institut Inter-regional de Cancerologie, Le Mans, France.
24
Service post urgences, CHU de FORT DE FRANCE, pôle RASSUR, Martinique, France.
25
Hopital Jean Minjoz, CHRU Besançon, Besançon, France.
26
Service d'Hemato-Oncologie, CHU Chartres, Chartres, France.
27
Hematologie clinique et therapie cellulaire, CHU Amiens, Amiens, France.
28
Service de rhumatologie, CHU Poitiers, Poitiers, France.
29
Cancer Genetics Department, Paoli-Calmettes Institute, Aix-Marseille University, Marseille, France.
30
Service d'Immuno-hematologie, Hôpital Saint Louis, Paris, France.
31
Service d'Hematologie, CHU de Nancy, Universite de Lorraine, Vandoeuvre les Nancy, Nancy, France.
32
Internal Medicine Department, Archet Hospital, CHU Nice, Nice, France.
33
Service d'Hematologie, CHR Mercy, Metz, France.
34
Unite d'Hematologie, CH Valence, Valence, France.
35
Service d'Hematologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France.
36
Service d'Hematologie, CHU de Brest, Brest, France.
37
Haematology Department, CHU UCL Namur, Yvoir, Belgium.
38
Hematologie clinique, CHU de Grenoble, La Tronche, France.
39
Departement d'oncologie, CHUV, Lausanne, Switzerland.
40
Unite d'oncologie medicale, Pôle medical 2, Hôpital Jacques Puel, Rodez, France.
41
CH Poissy, Saint-Germain-en-Laye, France.
42
Service Hematologie, Institut de Cancerologie Lucien Neuwirth, Saint-Priest-en-Jarez, France.
43
Hematologie, CHG Abbeville, Abbeville, France.
44
Institut Daniel Hollard, Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France.
45
Service hemato/oncologie, CH William Morey, Chalon sur Saône, France.
46
Hematologie clinique, Hôpital Avicenne, Bobigny, France.
47
Intergroupe Francophone du Myelome (IFM), Bobigny, France.
48
Service Hematologie, CH Bligny, Briis-sous-Forges, France.
49
Service Hematologie, CH Lyon Sud, Pierre Benite, France.
50
Service Hematologie, CHU Nantes, Nantes, France.
51
Laboratoire de Biologie Medicale OncoGènAuvergne; Departement d'oncogenetique, UMR INSERM 1240, Centre Jean Perrin, Clermont-Ferrand, France.
52
Service d'hematologie clinique, Pôle medecine de specialite, Centre Hospitalier Sud Francilien (CHSF), Corbeil-Essonnes, France.
53
Hematologie Clinique, CHU Nîmes, Nîmes, France.
54
Hematologie Clinique, CHU Dijon, Dijon, France.
55
Hematologie - Oncologie medicale, Centre Azureen de Cancerologie, Mougins, France.
56
Service d'Hematologie et d'Oncologie, CHU de Versailles, Le Chesnay, France.
57
INSERM U1035, Universite de Bordeaux, Bordeaux, France.
58
Hematologie Clinique, IHBN-CHU CAEN (University Hospital), Caen, France.
59
Rheumatology Department, Maison Blanche Hospital, Reims University Hospitals, Reims, France.
60
Unite d'Hematologie clinique, Groupement des hôpitaux de l'Institut Catholique (GHICL), Universite Catholique de Lille, Lille, France.
61
Departement d'hematologie clinique, CHU de Montpellier, Montpellier, France.
62
Service d'Oncologie medicale, CHU de La Guadeloupe, Pointe-a-Pitre, Guadeloupe.
63
Laboratory for Genomics in Myeloma, Institut Universitaire du Cancer and University Hospital, Centre de Recherche en Cancerologie de Toulouse, Toulouse, France.
64
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
65
Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, IDIBELL, Catalan Institute of Oncology; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
66
Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
67
Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
68
3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
69
Department of Hematology, University Hospital, Bydgoszcz, Poland.
70
Department of Haematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
71
Jagiellonian University Medical College, Department of Hematology, Cracow, Poland.
72
Gdynia Oncology Center, Gdynia and Department of Oncological Propedeutics, Medical University of Gdańsk, Gdańsk, Poland.
73
Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
74
Department of Bone Marrow Transplantation and Hematology-Oncology M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland.
75
Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
76
Holycross Cancer Center of Kielce, Hematology Clinic, Kielce, Poland.
77
Department of Oncology, Transplants and Advanced Technologies, Section of Hematology, Pisa University Hospital, Pisa, Italy.
78
Department of Hematology, Medical University of Lodz, Łódź, Poland.
79
Department of Experimental Hemato-oncology, Medical University of Lubli, Poland; Department of Hematology, St. John's Cancer Centre, Polish Myeloma Study Group, Lublin, Poland.
80
Hematology Department, Hospital 12 de Octubre, Universidad Complutense; CNIO, Madrid, Spain.
81
Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain.
82
Department of Biology, University of Pisa, Pisa, Italy.
83
Inserm U900, Institut Curie, PSL Research University, Mines ParisTech, Paris, France.
84
Teaching Hospital No1, Hematology Dept, Rzeszow, Poland.
85
Hematology Department, University Hospital of Salamanca, IBSAL, Salamanca, Spain.
86
Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
87
Department of Hematology, Copernicus Hospital, Torun, Poland.
88
Wroclaw Medical University, Wroclaw, Poland.
89
Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
90
Department of Genetics and Genomic Sciences and Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
91
Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France. mckayj@iarc.fr.
92
ProfilExpert, Lyon, France. charles.dumontet@chu-lyon.fr.
93
Hospices Civils de Lyon, Lyon, France. charles.dumontet@chu-lyon.fr.
94
INSERM 1052, CNRS 5286, CRCL, Lyon, France. charles.dumontet@chu-lyon.fr.
95
University of Lyon, Lyon, France. charles.dumontet@chu-lyon.fr.
PMID:
30967618
DOI:
10.1038/s41375-019-0452-6

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center